Improved wound healing in superficial wound infection through a-SMA upregulation and increased collagen density by the secretome of hypoxic mesenchymal stem cells
Open Access
- 1 January 2025
- journal article
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in SCRIPTA MEDICA
- Vol. 56 (6) , 727-735
Abstract
Background/Aim: Superficial wound infections cause delayed remodeling by suppressing the expression of Alpha-smooth muscle actin (a-SMA), which inhibits collagen synthesis. Secretomes derived from hypoxic mesenchymal stem cells (SH-MSCs) contain a variety of cytokines and growth factors that contribute to accelerated wound healing and infection suppression. This study aimed to investigate the effects of SH-MSC gel on the expression of the a-SMA gene and the collagen density in the skin tissue of rats with superficial wound infections. Methods: The research design utilised a post-test-only control group with a completely randomised format. The study sample consisted of 24 rats with superficial wound infections induced by Staphylococcus aureus bacteria at a concentration of 5 x 107 CFU/mL in 100 µL. The study included four groups: a healthy group, a negative control group, treatment group 1 (T1) receiving a 10 % dose of SH-MSCs gel and treatment group 2 (T2) receiving a 20 % dose of SH-MSCs gel. The expression of the a-SMA gene was analysed through qRT-PCR and collagen density was assessed using Masson's trichrome staining. Results: The qRT-PCR analysis indicated that the a-SMA gene expression was significantly elevated in the T2 group, registering the highest level at 10.03 ± 3.78. This was followed by the T1 group, which had a mean a-SMA gene expression of 4.96 ± 2.77. The negative control treatment group exhibited the lowest level of a-SMA expression, measuring at 0.46 ± 0.09. Additionally, collagen density analysis showed an increase in the T2 group, which had the highest collagen density at 35.68 ± 5.28, followed closely by the T1 group at 34.78 ± 1.72. The negative control group exhibited the lowest collagen density, recorded at 17.39 ± 2.47. Conclusion: The administration of SH-MSCs gel can enhance a-SMA gene expression and increase collagen density in a rat model of superficial wound infection.Keywords
All Related Versions
This publication has 36 references indexed in Scilit:
- MSCs-released TGFβ1 generate CD4+CD25+Foxp3+ in T-reg cells of human SLE PBMCJournal of the Formosan Medical Association, 2021
- Superoxide-induced Type I collagen secretion depends on prolyl 4-hydroxylasesBiochemical and Biophysical Research Communications, 2020
- Umbilical cord-derived mesenchymal stem cell extracts ameliorate atopic dermatitis in mice by reducing the T cell responsesScientific Reports, 2019
- Superficial incisional surgical site infection rate after cesarean section in obese women: a randomized controlled trial of subcuticular versus interrupted skin suturingArchives of Gynecology and Obstetrics, 2013
- Compensation of cATSCs-derived TGFβ1 and IL10 expressions was effectively modulated atopic dermatitisCell Death & Disease, 2013
- Emergence of Distinct Multiarmed Immunoregulatory Antigen-Presenting Cells during Persistent Viral InfectionCell Host & Microbe, 2012
- Role of interleukin-10 in breast cancerBreast Cancer Research and Treatment, 2011
- Fibroblasts and myofibroblasts in wound healing: Force generation and measurementJournal of Tissue Viability, 2011
- The regulation of IL-10 production by immune cellsNature Reviews Immunology, 2010
- Smooth muscle α‐actin expression and myofibroblast differentiation by TGFβ are dependent upon MK2Journal of Cellular Biochemistry, 2006